Has John Thompson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,066 in general payments to John Thompson, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Thompson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Thompson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Thompson, MD

Medical Oncology · Seattle, WANPI 1447328539

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,770 of the $12,066 with a category attached, or 72.7%. 9 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.3% of the total. Reporting peaked in 2021 at $8,116 and has fallen 91.8% since, to $664 in 2024.

$12,066in general payments, 2019–2025

Across 32 payments — averaging $377.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$3K
Regeneron$3K
E.r. Squibb & Sons, L.L.C.$2K
Pfizer$2K
Medtronic$717
Seagen Inc.$675
plus $842 from 3 others

$2,343,699in research payments, 2019–2025

Across 161 payments — averaging $14,557 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$1.1M
Pfizer$772K
Incyte Corporation$220K
Merck$145K
Gilead$30K
Hoffmann-la Roche Limited$28K
plus $17K from 2 others

What the payments were for

Consulting fees$8,77073%
Speaking & faculty fees$1,99117%
Travel & lodging$3353%
Food & beverage$9698%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	2	$3,294
Regeneron	1	$2,620
E.r. Squibb & Sons, L.L.C.	2	$2,200
Pfizer	4	$1,718
Medtronic	14	$717
Seagen Inc.	1	$675
AstraZeneca	6	$666
Foundation Medicine, Inc.	1	$136
Merck	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,066 in reported general payments places this provider in the 70th percentile of 162 medical oncology providers in Washington.

See all medical oncology providers in Washington →

Medicare billing

Part B allowed, 2024

$3,960

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Seattle

Bart ScottSeattle$1.3M
Petros GrivasSeattle$628K
Vijayakrishna GadiSeattle$573K
Evan YuSeattle$296K
Siddhartha DevarakondaSeattle$215K
David MaloneySeattle$150K
Gary LymanSeattle$130K
Rafic FarahSeattle$114K
Laura ChowSeattle$114K
Shailender BhatiaSeattle$107K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →